Simplifying Large Scale Single-Use Filtration While Decreasing Risk With A Novel Modular Approach
By Andre Grebe and Dr. Florian Mieth
![GettyImages-1441662840-lab-team-communication-collaboration GettyImages-1441662840-lab-team-communication-collaboration](https://vertassets.blob.core.windows.net/image/41158367/41158367-dc3b-4e98-ba3a-c94fc031ac87/375_250-gettyimages_1441662840_lab_team_communication_collaboration.jpg)
Filtration plays a critical role in assuring the safety and quality of biopharmaceutical products. Stainless steel multi-round housings are commonly used in conventional large-scale filtration processes, while filter assemblies with multiple components and connections provide a single-use alternative. Single-use systems offer flexibility and speed in the production of pharmaceuticals and vaccines. Large-scale production increases material consumption (due to the increased number of components involved), process complexity, and associated risks. To meet these challenges, Sartorius developed a modular platform-based approach called Maxicaps® MR that offers a simplified, standardized design with integrated functionality for large-scale filtration applications in protein- and virus-based therapy production processes.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.